Latest Breaking News On - Director merrill - Page 1 : comparemela.com

HC Wainwright Reaffirms Buy Rating for Iovance Biotherapeutics (NASDAQ:IOVA)

HC Wainwright Reaffirms Buy Rating for Iovance Biotherapeutics (NASDAQ:IOVA)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerIovance biotherapeuticsZurcher kantonalbank zurich cantonalbankMerrilla mcpeakYork mellon corpChicago partners investment groupWells fargo companySecurities exchange commissionMirae asset global investments coRaymond james financial services advisors incIovance biotherapeutics incFree reportModerate buyGet free reportDirector merrill

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13 45

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13 45
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesIovance biotherapeuticsMerrilla mcpeakPiper sandlerRaymond james financial services advisors incPrincipal financial group incSecurities exchange commissionIovance biotherapeutics incVanguard group incArtisan partners limited partnershipIovance biotherapeutics company profileKennedy capital managementGoldman sachs groupGet free reportDirector merrillExchange commission

Iovance Biotherapeutics (IOVA) Set to Announce Quarterly Earnings on Thursday

Iovance Biotherapeutics (IOVA) Set to Announce Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesIovance biotherapeuticsMerrilla mcpeakSecurities exchange commissionIovance biotherapeutics incGoldman sachs groupGet free reportDirector merrillExchange commission

Iovance Biotherapeutics, Inc (NASDAQ:IOVA) Given Average Rating of Buy by Analysts

Iovance Biotherapeutics, Inc (NASDAQ:IOVA) Given Average Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMerrilla mcpeakIovance biotherapeuticsFidelis capital partnersNisa investment advisorsQuadrant capital groupGoldman sachs groupChina universal asset management coAnnandale capitalIovance biotherapeutics incGet free reportMarketbeat ratingsDirector merrillCapital groupCapital partnersUniversal asset management

Short Interest in Iovance Biotherapeutics, Inc (NASDAQ:IOVA) Rises By 5 6%

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares, a growth of 5.6% from the March 31st total of 46,380,000 shares. Approximately 22.2% of the shares of the company are sold short. Based […]

United statesIovance biotherapeuticsPiper sandlerMerrilla mcpeakCharles schwab investment management incIovance biotherapeutics incGoldman sachs groupPrincipal financial group incIovance biotherapeutics company profileArtisan partners limited partnershipWells fargo companyVanguard group incGet free reportDirector merrillPartners limited partnershipFinancial group